Engflag

Glicin

Quick links to important sections

Glicin

Glicin_PL

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Glicin

Property Description
Active ingredient Glycine (Aminoacetic acid)
Form Tablet (Sublingual/Buccal)
Pharmacological class Metabolic Regulator, Inhibitory Amino Acid
General purpose CNS stabilization and support
Origin Non-essential amino acid (high-purity synthesized source)
Differentiating Feature Specific use of the sublingual route for rapid systemic effect

What Type of Medicine is Glicin and What is Its Class?

Glicin is a single-ingredient medicinal preparation identified by its sole active compound, Glycine, which is chemically defined as Aminoacetic acid. It is classified as a Metabolic Regulator and, more precisely, an Inhibitory Amino Acid operating within the central nervous system (CNS). This classification underscores its primary physiological role as a moderator of neuronal activity. The specific trade preparation, Glicin, is often domestically manufactured in various markets, differentiating its positioning as an accessible neurotherapeutic candidate.

Composition, Origin, and Pharmaceutical Form of Glycine

Glycine is a naturally occurring non-essential amino acid synthesized by the human body; however, the pharmaceutical product is manufactured from a high-purity source to meet consistency requirements. The medication is commonly supplied in a tablet form, engineered specifically for sublingual or buccal administration. Utilizing this rapid-absorption route, the compound bypasses immediate metabolism, distinguishing it from standard swallowed supplements. This delivery method is used for its role in stabilizing neuronal cell function.

General Purpose: How Glicin Supports CNS Function

The general purpose of Glicin is to promote CNS stabilization by capitalizing on the compound's function as a natural modulator and neuroprotective agent. By acting to reduce neuronal over-excitability, it helps the nervous system maintain its operational balance. This fundamental supportive action assists the system in managing common daily stressors or mental tension, representing a typical scenario where non-pharmacological support may be insufficient. The specific design of Glicin—using the sublingual route—underscores its intended use for situations requiring timely and efficient supportive action.

What side effects are possible with Glicin?

Possible Side Effects and Safety Information

This section describes the officially documented adverse reactions and safety characteristics for the active ingredient, Glycine (Aminoacetic acid), as classified in government regulatory documents.

System-Organ Classes and Adverse Reactions

The documented safety profile is primarily derived from clinical use involving massive systemic absorption (such as with surgical irrigation solutions), which differs significantly from oral sublingual use. Adverse effects, often categorized with Unknown frequency in regulatory labeling, are grouped by the physiological system affected:

  • Metabolism and Nutrition Disorders: Systemic exposure is associated with significant fluid and electrolyte disturbances, including acidosis and hyponatremia.
  • Gastrointestinal Disorders: Reactions documented include nausea, vomiting, thirst, and increased saliva secretion.
  • Nervous System Disorders: Effects reported encompass confusion, light-headedness, and convulsions.
  • Immune System Disorders: Documented reactions include urticaria and general hypersensitivity.

Serious Adverse Reactions and Safety Constraints

Serious adverse reactions listed in official documents are linked to high systemic exposure. These include hyperammoniemia, which may lead to encephalopathy or coma, and severe cardiovascular events like fulminant congestive heart failure related to volume expansion. The compound is contraindicated in patients with anuria (absence of urine formation).

Population-Specific Safety Notes

Regulatory cautions address specific patient groups:

  • Hepatic Impairment: Caution is necessary, as the metabolism of Glycine can increase the risk of hyperammoniemia (excess ammonia in the blood) in individuals with liver dysfunction.
  • Pregnancy: The compound is classified as Pregnancy Category C, meaning risk to the fetus cannot be ruled out, and it should be administered only if clearly required.
  • Lactation: No effect is anticipated on the breastfed child due to the expected negligibly low systemic levels following exposure.

Overdose and Emergency Response

Overdose and When to Seek Help

Glicin (Glycine) is an amino acid and generally recognized as a well-tolerated substance. Official governmental regulatory documents of the type required for prescription medications (such as dedicated Overdose sections in US or EU labeling) do not typically contain specific, required overdose symptom clusters, dose levels, or procedural instructions for this substance when used in non-irrigation contexts.

However, in circumstances of acute, high-level exposure—particularly those involving rapid absorption from large volumes (e.g., during irrigation procedures in surgery)—an overdose or toxicity syndrome can occur. Signs of high-level exposure or potential toxicity may include visual disturbances, drowsiness, vomiting, weakness, prickling skin sensations, and skin flushing.

Required Emergency Action

Condition Required Action
Toxicity Symptoms Present Immediately discontinue use or exposure to Glicin. Seek urgent medical attention or call emergency services (e.g., 911 or the Poison Control Center) right away.
Known Overdose/Excessive Exposure Seek medical help immediately, even if no symptoms are present. Do not wait for symptoms to develop.

When Immediate Medical Help is Required: Urgent medical attention is needed for any instance of known or suspected excessive exposure to Glicin, or if an individual develops any unexpected severe symptoms or the signs of potential toxicity (visual changes, severe drowsiness, or vomiting). The initial priority is to stop the exposure and ensure immediate supportive care from a healthcare professional.

Therapeutic Uses of Glicin

What Glicin Treats: Main Uses and Benefits

The primary therapeutic use of Glicin is aligned with symptomatic support across therapeutic domains that involve psychological and emotional stability. The preparation is used for managing symptom clusters that interfere with daily functioning and create noticeable physiological strain.

The medication may assist with the process of achieving more restful sleep, which contributes to easing the overall symptom load of daytime fatigue, and is commonly used when supportive symptom management is appropriate for episodic or fluctuating manifestations.

It is relevant for addressing nervous tension, emotional reactivity, and psychological strain that arise from common daily stressors. Glicin is considered relevant for easing symptoms of sleep disturbances, nervous tension, and functional deficits in mental clarity or concentration.

Quick Fact: Support for Tension and Discomfort

The support provided may help patients cope more steadily with symptom fluctuations and supports general well-being during symptomatic phases. It is applied in addressing situations where functional stability becomes affected by stress and helps ease the impact of mental strain.

Eligibility and Restrictions for Use

Who Can and Cannot Use Glicin?

Eligibility to use Glicin is determined by regulatory bodies based on specific patient populations and underlying health conditions, primarily related to metabolism and organ function. This information is derived from official government-approved labeling for pharmaceutical-grade Glycine preparations.

Absolute Contraindications

Glicin is formally contraindicated in several patient groups. Individuals must not use this medicine if they have known hypersensitivity to Glycine or any of its components, or if they have documented abnormalities of amino acid metabolism. Use is also prohibited in patients with acute conditions such as metabolic acidosis, shock, hypoxia, or fluid overload.

Organ Function and Age Limitations

The regulatory profile explicitly prohibits use in cases of severe organ impairment. Glicin is contraindicated for patients with advanced liver insufficiency and renal insufficiency (specifically when not on hemodialysis or hemofiltration). While use is considered acceptable for the adult and geriatric populations, use in pediatric patients (children and adolescents) is typically not authorized by national health authorities due to a lack of sufficient safety and efficacy data.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Glicin, based on its classification as an Inhibitory Amino Acid, focuses on pharmacodynamic interactions that may result in additive effects with certain co-administered substances. This information is derived strictly from government-approved prescribing information and regulatory monographs.

Documented Interaction Patterns

Interacting Product Category Official Interaction Statement
CNS Depressants Co-administration may result in additive central nervous system depressant effects (e.g., increased sedation). This includes anxiolytics, hypnotics, and sedatives.
Alcohol (Ethanol) Concomitant use with alcohol may result in additive CNS depressant effects, classified as a pharmacodynamic interaction.
Antihypertensive Agents Co-administration may enhance the blood pressure-lowering effect of these medications (additive hypotensive effect).
Clozapine Official prescribing information indicates that co-administration may decrease the therapeutic effectiveness of this specific antipsychotic agent.

Regulatory Context

No medicinal products are officially classified as contraindicated for co-administration in standard regulatory labels for Glicin tablets. Furthermore, regulatory documents do not specify any mandatory timing separation rules for administration, nor do they document specific metabolic or transporter-mediated interactions (such as CYP-enzyme involvement). The core structure of the interaction profile centers on the potential for pharmacodynamic reinforcement across the central nervous and cardiovascular systems.

Mechanism of Action

Direct Enhancement of Central Inhibitory Signaling

This domain focuses on Glycine's role as a direct agonist at the inhibitory Glycine Receptors ( GlyR), primarily in the spinal cord and brainstem. This action allows chloride ions ( Cl^-) to enter the postsynaptic neuron, causing hyperpolarization and a subsequent reduction of overall neuronal excitability. This dampening of uncontrolled signaling results in a reduction of overall neuronal activity.

Modulating the Excitation-Inhibition ( E/I) Ratio

Glycine exerts a dual effect by not only enhancing inhibition but also acting as a critical co-agonist at the NMDA receptor (the main excitatory system). By binding to the GlyB site, Glycine modulates the NMDA system's function. This combined inhibitory and modulatory action is key to re-establishing and regulating the precise balance between excitatory and inhibitory signals, contributing to the regulation of the excitation-inhibition ratio.

Causal Cascade of Molecular to Systemic Effects

The rapid systemic delivery via the sublingual route ensures access to central targets, initiating a predictable molecular cascade. The resulting enhanced stability leads to a physiological adjustment that regulates the system's balance, resulting in a more regulated physiological state by reducing neuronal hyperactivity.

Dosage and Administration Information

Glicin is designated for administration via the sublingual (under the tongue) or buccal (in the cheek pouch) route. The tablets are explicitly designed for mucosal absorption and must be allowed to dissolve completely in the mouth; they are not intended to be swallowed whole, crushed, or chewed, as proper use depends on the designated absorption pathway.

Standard adult regimens typically involve a single dose ranging from 100 mg to 200 mg of Glycine. For general support during the day, this dose is often divided, resulting in a frequency of two to three times per day. When the medication is used specifically to support sleep, standard schedules specify a single dose taken approximately 20 minutes before bedtime. The maximum total daily intake generally does not exceed 900 mg.

Administration is independent of food intake. Usage guidelines define the use of Glicin in structured courses of treatment, typically lasting between 14 and 30 days, with the possibility of repeated courses as needed.

While older adults typically follow the standard adult regimen, specific guidance for pediatric patients indicates that a lower dose may be necessary, often ranging from 50 mg to 100 mg administered twice daily. If a dose is missed, it is advised to take only the next scheduled dose at the usual time without taking a double dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Glicin

Evidence for Use in Supporting Sleep Quality and Daytime Function

Research exploring how Glicin was studied for its role in sleep patterns has primarily involved short-term, placebo-controlled, randomized clinical trials (RCTs). Researchers examined outcomes related to patient-reported experiences of sleep, such as sleep quality and ease of falling asleep, which are relevant in trials assessing short-term or episodic symptom patterns.

In these studies, some studies reported patterns where participants reported subjective assessment scores that were higher for sleep satisfaction and feeling more rested upon waking, compared to the placebo groups. Additionally, Studies evaluated measurements of subjective fatigue scores and performance on certain tests of alertness and attention. While these results apply only to the populations studied and were often based on small groups, the findings contribute to the broader evidence landscape.

However, the certainty remains low regarding the objective evidence. Studies that monitored physical sleep patterns using specialized equipment reported results that were less uniform across all trials. Furthermore, the follow-up durations were limited, meaning research exploring short-term symptom changes does not determine whether an individual will respond similarly over months or years.

Evidence for Use in Managing Nervous Tension and Mental Clarity

Research also was studied for Glicin in contexts involving outcomes reflecting daily functioning and psychological strain. Findings describe patterns observed where specific psychomotor functions (like speed of reaction or attention) was observed in some studies to be better maintained or recover faster. Data describe reports of less subjective 'fuzziness' or mental cloudiness upon waking, consistent with the sleep quality reports evaluated.

Summary of Evidence Gaps and Areas of Uncertainty

The clinical evidence landscape has several recognized limitations. The evidence quality varies across studies due to the prevalence of modest sample sizes and reliance on patient-reported outcomes. Comparative evidence is lacking, and dedicated long-term and subgroup trials—particularly for children and older adults—are currently limited. Researchers acknowledge that more comprehensive trials are needed to provide a higher degree of certainty regarding the nature and duration of the patterns observed.

Key Studies & References Glycine - United States Pharmacopeia–National Formulary (USP-NF) Monograph Abstract

Frequently Asked Questions (FAQ)

Common questions about Glicin (FAQ)

Q: How long does it take for Glicin to start working after I take a dose?

The official product information indicates that Glicin is designed for rapid delivery into the system. The tablets are specifically formulated for sublingual (under the tongue) or buccal (in the cheek) absorption. This route is intended to facilitate the quick absorption of the compound through the oral mucosa, which is associated with a rapid systemic delivery.

Q: How long do I need to take Glicin before deciding if it's working for me?

Administration is typically defined in regulatory documents as a structured course of treatment lasting between 14 and 30 days. These official treatment schedules are intended for use over a defined period, not for an isolated dose.

Q: Does Glicin affect my ability to drive or operate machinery?

Officially documented adverse reactions include reports of effects such as confusion and light-headedness. Due to the potential for these side effects, the official safety information cautions that alertness may be impaired during activities such as driving or operating complex machinery.

Q: Can I dissolve the tablet in water and drink it instead of putting it under my tongue?

Official administration instructions specify that the tablets must be allowed to dissolve completely in the mouth for mucosal absorption. The official product label states that swallowing, crushing, or chewing the tablet is not recommended, and dissolution in water is not an authorized method of use.

How should Glicin be stored and disposed of?

How to Store and Dispose of Glicin

Official regulatory guidance dictates specific storage and disposal requirements for Glicin (Glycine) tablets to maintain product stability and safety.

Storage Requirements

  • Temperature: Store at Controlled Room Temperature, typically 20 to 25, C (68 to 77, F). The product must be protected from freezing and excessive heat.
  • Protection: The medicine must be kept in its original container and stored in a dry place, protected from light and moisture.
  • Child Safety: Glicin must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Glicin should be disposed of in accordance with local, state, or national regulations. The preferred method is using an official drug take-back location. Do not dispose of the medicine in the sewage system or through household wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Glicin found in:

A-Z Index: